Open original FDA record ↗Recall record
- FDA identifier
- Z-1295-2024
- Company in FDA record
- MEDLINE INDUSTRIES, LP - Northfield
- FDA classification date
- Mar 14, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Product failed sterility testing.
Source facts
- Action
- The recalling firm originally initiated the recall by letter dated and issued on 1/23/2024 via email regarding lot #10322040003. The letter explained the issue, risk, and that no reports of illness or injury have been received due to this issue. The required actions listed in the letter were: (1) Immediately check your stock for the affected item and lot numbers listed on the attachment and quarantine all affected product; (2) Return the enclosed response form. Once the response form is received, the consignee will be sent return labels and the account will receive credit when the returned product is received; (3) If the product has been transferred to another individual, department, or location, the consignee is to notify their customer and have them return the affected product to the consignee for subsequent return to the recalling firm. A list of impacted CVS locations was included in the letter. When the additional sterility results were received, the recall was expanded to include the other lots by letter dated and issued on 2/1/2024 via email. The letter explained that additional lot numbers are now impacted and the remainder of the letter contained the same information as the initial letter on 1/23/2024.
- Initiated
- 2024-01-23
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the states of AL, CA, FL, IN, MI, MO, NJ, NY, PA, RI, SC, TN, TX. and VA. There was no foreign/government/military distribution.
- Recall number
- Z-1295-2024
- Recall status
- Open, Classified
- CDRH record ID
- 206176
- FDA classified
- 2024-03-14
- Recall event number
- 94036